Compare VSTS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSTS | OPK |
|---|---|---|
| Founded | 1936 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 921.2M |
| IPO Year | 2023 | 2011 |
| Metric | VSTS | OPK |
|---|---|---|
| Price | $11.99 | $1.10 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $5.88 | $1.60 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,734,839,000.00 | $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.67 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.98 | $0.98 |
| 52 Week High | $10.38 | $1.60 |
| Indicator | VSTS | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 78.26 | 37.19 |
| Support Level | $7.24 | $0.98 |
| Resistance Level | N/A | $1.25 |
| Average True Range (ATR) | 0.43 | 0.04 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 86.40 | 43.48 |
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.